Rigel Pharmaceuticals Inc (RIGL) Event Aug. 02, 2022, 00:00 UTC (99% Positive) RIGEL PHARMACEUTICALS INC (RIGL) Reports 163% Profit Growth for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:31 a.m. 🏢 Rigel Pharmaceuticals Inc (RIGL) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-02 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $25.68M $-40.94M $66.62M +162.73% 📉 Total Assets $167.33M $128.00M $39.33M +30.72% 📈 Stockholders' Equity $68.11M $-1.28B $1.35B +105.32% 📈 Operating Income/Loss $28.71M $-39.23M $67.93M +173.18% 📉 SG&A Expense $44.50M $54.38M $-9.88M -18.17% 📈 Earningspersharebasic $0.15 $-0.24 $0.39 +162.50% 📈 Earningspersharediluted $0.15 $-0.24 $0.39 +162.50% 📈 📈 Financial Trend Analysis 💰 Profitability improved with +162.7% net income growth • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Rigel Pharmaceuticals Inc (RIGL) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
💰 Profitability improved with +162.7% net income growth • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document